Grantham, Mayo, Van Otterloo & Co (GMO)
HUM icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Humana HUM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-343,000
Closed -$70M – 611
2016
Q4 		$70M Hold
343,000
– – 0.38% 71
2016
Q3 		$60.7M Buy
343,000
+217,100
+172% +$37.7M 0.29% 88
2016
Q2 		$22.6M Buy
+125,900
New +$22.4M 0.09% 155

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HUM Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Humana (HUM) stake by 27% in Q1 2026, buying an estimated $1.98M and bringing the position to 44,950 shares worth $7.79M. The position accounts for 0.02% of the portfolio, ranked #270.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HUM in Q2 2013 and has held it in 40 quarters since. The position peaked at $245M in Q3 2015. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 44,950 shares of Humana worth $7.79M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 9,654 Humana shares in Q1 2026, an estimated $1.98M.
  • Humana made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #270 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Humana in Q2 2013 and has held it in 40 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Humana position peaked at $245M in Q3 2015.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.